Company profile
MYRIAD GENETICS INC
NASDAQ:MYGNBiotechnology: In Vitro & In Vivo Diagnostic Substances
Clinical trials (0)
No records yet.
FDA applications (0)
No records yet.
Company profile
No records yet.
No records yet.